NCT04672551: EMDR_PTSD_MI

EMDR Treatment in PTSD Following Cardiac Events

Recruiting now NA Last updated 31 July 2024

What this trial tests

NA trial testing EMDR Treatment in Posttraumatic Stress Disorder in 60 participants. Currently enrolling.

Timeline

21 November 2020

Primary endpoint
30 November 2026

30 November 2026

Quick facts

Lead sponsor	University of Zurich
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	21 November 2020
Primary completion	30 November 2026
Estimated completion	30 November 2026
Sites	1 location across Switzerland

Drugs / interventions tested

• EMDR Treatment

Conditions studied

• Posttraumatic Stress Disorder — all drugs for Posttraumatic Stress Disorder →
• Myocardial Infarction — all drugs for Myocardial Infarction →
• Eye Movement Desensitization and Reprocessing — all drugs for Eye Movement Desensitization and Reprocessing →

Sponsor

University of Zurich

Who can join

Adults 18 to 70, any sex, with Posttraumatic Stress Disorder or Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiac events can often result in debilitating and persistent psychological symptoms. A key question involves whether optimal treatment of cardiac-induced posttraumatic stress disorder (PTSD) reduces PTSD symptoms and thereby may offset the risk of recurrent or worsening cardiovascular disease. Cardiac-induced PTSD 1) is prevalent, 2) features symptoms unique to internal ongoing somatic threat, with fears and worries that can be distinguished from PTSD resulting from external causes, 3) is persistent, 4) is associated with negative physical and emotional consequences, and 5) has not been the subject of randomized-controlled treatment trials (RCT). There is preliminary evidence suggesting that patients with cardiac-disease induced PTSD might particularly profit from EMDR. Nevertheless, this possibility has not been tested in cardiac-induced PTSD. Currently, patients with cardiac-induced PTSD are not routinely offered trauma-focused therapies, with a lack of scientific evidence likely being one major reason for this omission. If our proposed RCT shows that EMDR can be an effective treatment for patients with ACS-induced PTSD, EMDR could be routinely implemented as first-line treatment. The RCT outcomes might inform larger trials to test whether poor prognosis in terms of major adverse cardiovascular events can be improved through EMDR in patients with cardiac-induced PTSD.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.